Live Updates

ID 12/25 Response to Consultation Paper on Proposed Inclusion of Additional Criteria for Additional Tier 1 and Tier 2 Capital Instruments for Insurers

AI Analysis

Executive Summary

This MAS circular (ID 12/25) announces the Response to Consultation Paper on adding new criteria for insurers' Additional Tier 1 (AT1) and Tier 2 capital instruments under the RBC 2 framework, finalizing enhancements to strengthen capital quality and loss absorption. It matters because it directly updates Notices 133 and FHC-N133, impacting how insurers recognize capital instruments from 1 January 2026, with a restriction to non-retail investors in Singapore, aligning Singapore's regime with global standards like IAIS ICS. #

What Changed

- Additional Criteria for AT1 and Tier 2 Instruments: Introduces new eligibility criteria for capital instruments to qualify as AT1 or Tier 2 under RBC 2, enhancing loss absorption features (e.g., similar to full flexibility, non-default on non-payment, and maturity restrictions seen in international frameworks). - Investor Restriction: Instruments must be sold only to persons who are not retail investors in Singapore to qualify, reducing retail exposure risk. - Notice Amendments: Formalizes updates via ID 15/25, amending Notice 133 (for insurers) and Notice FHC-N133 (for Designated Financial Holding Companies), effective 1 January 2026. These align with global standards, e.g., IAIS ICS Tier 1/2 definitions requiring look-through for underlying exposures and high-quality loss absorption.

What You Need To Do

  • Review Existing/Planned Issuances
  • Update Capital Planning
  • Investor Documentation
  • Reporting & Disclosure
  • Training & Governance

Key Dates

27 March 2025 Consultation Paper P001-2025 start date on proposed equity counter-cyclical adjustment and AT1/Tier 2 criteria.
28 April 2025 Consultation closing date.
09 October 2025 MAS Response to Consultation issued (this circular ID 12/25).
08 December 2025 ID 15/25 published, updating Notices 133 and FHC-N133.
08 December 2025 Last revised date for Notices FHC-N133 and 133.
1 January 2026 Effective date for amended notices; new criteria apply to capital instruments sold only to non-retail investors.

Compliance Impact

Urgency: High โ€“ Effective 1 January 2026 (less than 1 month from today, 6 Feb 2026), requiring immediate review of issuances to avoid disqualification of capital, potential RBC shortfalls, or supervisory action. Matters for capital adequacy amid RBC 2 enhancements, as non-compliant instruments reduce eligible capital, increasing solvency risk; aligns with IAIS but adds local retail protection.

Who is Affected

Direct InsurersReinsurersFinancial Holding Companies

Summary

Informs insurers on the issuance of the Response to Consultation Paper on Proposed Inclusion of Additional Criteria for Additional Tier 1 and Tier 2 Capital Instruments for Insurers.

Relevant Firm Types

Insurance
View Original on MAS Back to Feed

Share this update